YD Bio Limited Ordinary Shares (YDES) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

YD Bio Limited Ordinary Shares (YDES) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $450.5M, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.12 to the broader market. YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. Led by Ethan Shen, public since 2025-08-29.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for YDES as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →